Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ANIK

Anika Therapeutics Inc

May 22 • 04:00PM ET

14.88

-0.14 -0.93 %

Healthcare • Drug Manufacturers - Specialty & Generic • USA • Micro • NASD

Peers: VCEL XTNT XERS ATEC ENTA

| Held by: VTI IWM VXF IWN AVUV SCHA VTWO DFMC DFSV DFAS

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.79	Insider Own	5.59%	Shs Outstand	13.36M	Perf Week	-0.20%
Market Cap	197.99M	Forward P/E	96.00	EPS next Y	0.15	Insider Trans	2.37%	Shs Float	12.56M	Perf Month	-3.50%
Enterprise Value	182.71M	PEG	1.17	EPS next Q	-0.08	Inst Own	93.83%	Short Float	4.40%	Perf Quarter	36.26%
Income	-11.06M	P/S	1.70	EPS this Y	-209.09%	Inst Trans	1.32%	Short Ratio	4.17	Perf Half Y	56.30%
Sales	116.26M	P/B	1.48	EPS next Y	229.17%	ROA	-5.99%	Short Interest	0.55M	Perf YTD	54.84%
Book/sh	10.02	P/C	4.83	EPS next 5Y	81.71%	ROE	-7.85%	52W High	16.24 -8.37%	Perf Year	26.42%
Cash/sh	3.08	P/FCF	190.38	EPS past 3/5Y	9.40% 14.76%	ROIC	-7.02%	52W Low	7.87 89.07%	Perf 3Y	-44.85%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-10.28% -2.86%	Gross Margin	58.59%	Volatility	3.18% 5.66%	Perf 5Y	-66.23%
Dividend TTM	-	EV/Sales	1.57	EPS Y/Y TTM	79.57%	Oper. Margin	-10.54%	ATR (14)	0.68	Perf 10Y	-67.62%
Dividend Ex-Date	-	Quick Ratio	3.37	Sales Y/Y TTM	-15.41%	Profit Margin	-9.52%	RSI (14)	50.71	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	4.46	EPS Q/Q	-9.65%	SMA20	1.08%	Beta	0.21	Target Price	17.50
Payout	-	Debt/Eq	0.19	Sales Q/Q	13.16%	SMA50	0.66%	Rel Volume	0.38	Prev Close	15.02
Employees	235	LT Debt/Eq	0.18	Earnings	Apr 29 BMO	SMA200	34.54%	Avg Volume	132.30K	Price	14.88
IPO	May 03, 1993	Option/Short	Yes / Yes	EPS/Sales Surpr.	485.71% 5.22%	Trades		Volume	50,841	Change	-0.93%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)